“Global Immunochemistry Reagents, Analyzers and Test Kits market set to grow to $34bn by 2024” says Visiongain report

01 October 2019
Pharma

Visiongain has launched a new pharma report Immunochemistry Reagents, Analyzers and Test Kits Market: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.

Immunochemistry technologies have evolved significantly over the years and now offer critical testing in all areas. High incidences of cancer, infectious diseases and cardiovascular diseases globally will fuel the demand for better disease specific immunochemistry tests.

The lead analyst of the report commented "Established markets such as the US and Western Europe dominate the global immunochemistry market. However, these markets are restrained by reduced healthcare budgets and increased regulatory pressures on device development and approval, which now requires evidence of clinical cost-effectiveness before approval is given.

There is therefore more opportunity for market penetration and larger sales volumes in emerging countries, such as India and China, as these countries remain relatively under penetrated and their diagnostic testing markets offer huge opportunities, especially with the vast population pool."

Leading companies featured in the report include Abbott, bioMerieux, Danaher, Fujirebio, Ortho Clinical Diagnostics, Roche, Siemens, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare Pvt. Ltd. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever